Rueda Altez, Maria S.
Kimberlin, David W.
Article History
Received: 26 November 2023
Accepted: 1 December 2023
First Online: 22 December 2023
Competing interests
: Dr. Rueda-Altez has no conflicts of interest to disclose. Dr. Kimberlin was the site Principal Investigator on Gilead’s pediatric study of remdesivir; all monies went directly to UAB.